Consolidated statements of changes in equity
(thousands of €) |
Share capital |
Share |
Translation |
Other |
Accumul. |
Total |
On 1 January 2019 |
236,540 |
1,277,780 |
(1,557) |
(735) |
(297,779) |
1,214,249 |
Change in accounting policy (modified retrospective application IFRS 16) |
|
|
|
|
416 |
416 |
Restated total equity at 1 January 2019 |
236,540 |
1,277,780 |
(1,557) |
(735) |
(297,363) |
1,214,665 |
Net profit |
|
|
|
|
149,845 |
149,845 |
Other comprehensive income/loss (-) |
|
|
415 |
(4,107) |
|
(3,692) |
Total comprehensive income/loss (-) |
|
|
415 |
(4,107) |
149,845 |
146,154 |
Share-based compensation |
|
|
|
|
38,297 |
38,297 |
Derecognition of financial liability from share subscription agreement and warrant A |
|
135,702 |
|
|
|
135,702 |
Issue of new shares |
36,945 |
923,142 |
|
|
|
960,087 |
Share issue costs |
(4,447) |
|
|
|
|
(4,447) |
Exercise of warrant A by Gilead |
14,162 |
353,873 |
|
|
|
368,035 |
Exercise of subscription rights |
4,082 |
13,085 |
|
|
|
17,167 |
On 31 December 2019 |
287,282 |
2,703,583 |
(1,142) |
(4,842) |
(109,223) |
2,875,658 |
|
|
|
|
|
|
|
On 1 January 2020 |
287,282 |
2,703,583 |
(1,142) |
(4,842) |
(109,223) |
2,875,658 |
Net loss |
|
|
|
|
(305,436) |
(305,436) |
Other comprehensive loss |
|
|
(2,047) |
(6,065) |
|
(8,112) |
Total comprehensive loss |
|
|
(2,047) |
(6,065) |
(305,436) |
(313,548) |
Share-based compensation |
|
|
|
|
79,959 |
79,959 |
Exercise of subscription rights |
4,031 |
24,257 |
|
|
|
28,288 |
On 31 December 2020 |
291,312 |
2,727,840 |
(3,189) |
(10,907) |
(334,701) |
2,670,355 |
The accompanying notes form an integral part of these financial statements.